NEW YORK (GenomeWeb News) — Epitome Biosystems has received a $500,000 Phase IIB Small Business Innovation Research grant from the National Science foundation, the company said today.
 
Epitome will use the cash to help it develop a technology that measures ”key tyrosine phosphorylation sites that have important roles in many cellular and drug responses,” the company said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.